Evidence map›Paper›PMID 34789465›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2021

Discordant diagnostic criteria for pneumonia in COPD trials: a review.

Robert A Wise, Mona Bafadhel, Courtney Crim, Gerard J Criner, Nicola C Day, David M G Halpin, MeiLan K Han, Peter Lange, David A Lipson, Fernando J Martinez and 6 more

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. How inhaled corticosteroids target inflammation in COPD.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 4 countries.

Robert A WiseDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-8353-2349
Mona BafadhelNuffield Dept of Medicine, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-9993-2478
Courtney CrimClinical Sciences - Respiratory, GSK, Research Triangle Park, NC, USA.
Gerard J CrinerLewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Nicola C DayGlaxoSmithKline, GSK House, Brentford, UK.
David M G HalpinUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
MeiLan K HanUniversity of Michigan, Pulmonary & Critical Care, Ann Arbor, MI, USA.
Peter LangeSection of Epidemiology, Dept of Public Health, University of Copenhagen, Copenhagen, Denmark.
David A LipsonClinical Sciences, GSK, Collegeville, PA, USA.ORCID https://orcid.org/0000-0001-6732-4593
Fernando J MartinezNew York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
Diego J MaselliDept of Medicine, University of Texas Health at San Antonio, San Antonio, TX, USA.ORCID https://orcid.org/0000-0001-8010-0260
Dawn MidwinterGlaxoSmithKline, GSK House, Brentford, UK.ORCID https://orcid.org/0000-0003-2434-1152
Dave SinghCentre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundation Hospital Trust, Manchester, UK.
Maeva ZysmanService des Maladies Respiratoires, CHU Bordeaux, Pessac, France.
Mark T DransfieldDivision of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Richard E K RussellNuffield Dept of Medicine, University of Oxford, Oxford, UK richard.russell@ndm.ox.ac.uk.ORCID https://orcid.org/0000-0002-3890-7201
GlaxoSmithKline (United Kingdom) · GBUniversity of Oxford · GBCentre Hospitalier Universitaire de Bordeaux · FRGlaxoSmithKline (United States) · USJohns Hopkins University · USManchester Academic Health Science Centre · GBNewYork–Presbyterian Hospital · USResearch Triangle Park Foundation · USTemple University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Alabama at Birmingham · USUniversity of Copenhagen · DKUniversity of Exeter · GBUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhaled corticosteroids (ICS) have a class effect of increasing pneumonia risk in patients with COPD. However, pneumonia incidence varies widely across clinical trials of ICS use in COPD. This review clarifies methodological differences in defining and recording pneumonia events in these trials and discusses factors that could contribute to the varying pneumonia incidence. Literature searches and screening yielded 40 relevant references for inclusion. Methods used to capture pneumonia events in these studies included investigator-reported pneumonia adverse events, standardised list of signs or symptoms, radiographic confirmation of suspected cases and/or confirmation by an independent clinical end-point committee. In general, more stringent pneumonia diagnosis criteria led to lower reported pneumonia incidence rates. In addition, studies varied in design and population characteristics, including exacerbation history and lung function, factors that probably contribute to the varying pneumonia incidence. As such, cross-trial comparisons are problematic. A minimal set of standardised criteria for diagnosis and reporting of pneumonia should be used in COPD studies, as well as reporting of patients' pneumonia history at baseline, to allow comparison of pneumonia rates between trials. Currently, within-trial comparison of ICS-containing

Indexed as

PneumoniaPulmonary Disease, Chronic ObstructiveAdministration, InhalationAdrenal Cortex HormonesHumansAdrenal Cortex Hormones

Identifiers

PMID34789465
PMCPMC9488621
OpenAlexW3214659796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.